Aroa Biosurgery hopes for sales boost after study finds high healing rates

Aroa Biosurgery hopes for sales boost after study finds high healing rates
Aroa founder Brian Ward says the largest study to date of its tissue repair products bodes well for the firm. (Image: Aroa Biosurgery)
Rebecca Stevenson
Aroa Biosurgery founder Brian Ward says a new large study proving the efficacy and cost saving of its tissue repair products should help to convince conservative surgeons to use them. In late December Australian Securities Exchange (ASX) listed Aroa announced a peer-reviewed study of 120 inpatients for two of its treatments, Myriad Matrix and Myriad Morcells, in lower limb reconstructions. The study, which was published in a plastic and reconstructive surgery journal in December, found one application of Myriad achieved tissue coverag...

More Markets

NZ sharemarket braces for Trump's 'Liberation Day'
Markets Market Close

NZ sharemarket braces for Trump's 'Liberation Day'

The S&P/NZX 50 Index closed at 12,320.19, up 7.59 points or 0.062%.

Graham Skellern 02 Apr 2025
Westpac Bank’s Eckhold says April cut likely wrong move
Economy

Westpac Bank’s Eckhold says April cut likely wrong move

Economists are widely expecting a 25 bps rate cut next week. 

Rebecca Howard 02 Apr 2025
The simple strategy behind Dairyworks
Primary Sector

The simple strategy behind Dairyworks

Is New Zealand still fixated on the 1kg block of cheese?

Riley Kennedy 02 Apr 2025
Trump-era FX 'compounding' margin losses, analysts say
Retail

Trump-era FX 'compounding' margin losses, analysts say

"Liberation day" could make matters worse, says Kiwibank’s Kerr.

Gregor Thompson 02 Apr 2025